Live
- Mega job mela on Dec 28
- Amit Shah’s removal from Union Cabinet demanded
- SCR to run weekly special trains
- TG to roll out Clean and Green Energy Policy soon: Bhatti
- Youth must take up farming, allied activities: Dhankhar
- Blankets, fruits distributed to mark Vajpayee’s birth anniv
- Hyderabad: Techie turns traffic volunteer, promotes road safety
- Visakha Dairy head Adari Anand joins BJP
- Christmas celebrated with religious fervour
- Christmas celebrated with gaiety
Covaxin still waiting for WHO nod
Covaxin still waiting for WHO nod
Bharat Biotech, a city-based bio-technology firm, on Friday said it has submitted all the data pertaining to its Covid-19 vaccine ‘Covaxin’ to the World health Organisation (WHO) for emergency use listing (EUL) and is awaiting feedback from the global health watchdog
Hyderabad: Bharat Biotech, a city-based bio-technology firm, on Friday said it has submitted all the data pertaining to its Covid-19 vaccine 'Covaxin' to the World health Organisation (WHO) for emergency use listing (EUL) and is awaiting feedback from the global health watchdog.
The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is 'yet to be confirmed', according to the update available on WHO website. A tweet from biotech firm goes reading: "#Covaxin" clinical trial data was fully compiled and available in June 2021. All data submitted for EUL application to WHO in early July. We have responded to any clarifications sought by #WHO and are awaiting further feedback,"
As a responsible manufacturer with past approvals for its other vaccines, the company said it would not find it appropriate to speculate or comment on approval process and its timelines, it further said that they are continuing to work diligently on obtaining WHO EUL at the earliest, the vaccine maker added in a series of tweets.
In an update on its website, the WHO said it began rolling data of the vaccine on July 6. Rolling data allows the global health watchdog to start its review right away, as information continues to come in, to accelerate the overall review process.
Suchitra Ella, joint managing director of Bharat Biotech recently had earlier said the EUL process is a step closer to the final decision on Covaxin's 'global acceptance'.
